查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404689

腦血栓切除裝置市場規模、佔有率、趨勢分析報告：按產品、最終用途、按地區、細分市場預測，2024-2030 年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

腦血栓切除裝置市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球腦血栓切除設備市場規模將達11億美元，2024年至2030年複合年成長率為6.87%。

市場成長是由多種因素推動的，例如中風盛行率增加、不健康生活方式的增加、微創手術需求的增加以及市場參與企業採取的各種策略性舉措。Masu。與傳統的開顱手術相比，這些設備具有簡化傷口縫合和加速創傷治療的優點。例如，易於進入顱內空間、微創性以及與腦血栓切除裝置相關的先進設計和功能簡化了困難的手術。

此外，所有年齡層的人對更美觀、更自然的外觀越來越感興趣，以及微創手術期間更少的失血也是市場成長的關鍵促進因素。此類手術預計將比侵入性手術更有助於減少創傷並促進更快的康復。如上所述，由於腦血栓切除裝置可減少失血並加快恢復速度，因此對微創手術的需求預計將會增加。此外，技術先進產品的推出和快速的產品核可流程預計將在預測期內推動市場成長。各種其他技術已被用於開發用於治療 AIS 和相關病症的腦血栓切除裝置。例如，2023年6月，Penumbra推出了閃電Bolt7動脈血栓切除系統。該設備有助於區分血塊和血流。

腦血栓切除設備市場報告亮點：

  • 從產品來看，由於急性缺血性腦中風上升以及主要市場參與企業增加產品推出，血栓切除設備在 2023 年佔據市場主導地位，佔有率為 58.24%。
  • 按最終用途分類，由於醫院醫療設施的改善和先進設備的配備，醫院細分市場在2023年佔據市場主導地位，佔有率為71.25%。
  • 由於急性缺血性腦中風患者的增加，歐洲在 2023 年以 32.74% 的最大銷售佔有率引領市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章腦血栓切除裝置市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 腦血栓切除裝置市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章腦血栓切除裝置市場：產品估算與趨勢分析

  • 定義和範圍
  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品分類的腦血栓切除設備市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第5章腦血栓切除裝置市場：最終用途估計與趨勢分析

  • 定義和範圍
  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 依最終用途分類的腦血栓切除裝置市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第6章腦血栓切除裝置市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2023年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030年市場應用、預測及趨勢分析
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Medtronic
    • Acandis GmbH
    • Phenox GmbH
    • Stryker
    • Penumbra, Inc.
    • Vesalio
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.10 billion by 2030, growing at 6.87% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2023, with a share of 58.24% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players
  • Based on end-use, hospital segment dominated the market in 2023 with a share of 71.25% due to improving health care facilities and the availability of advanced equipment in the hospitals
  • Europe led the market with the maximum revenue share of 32.74% in 2023, owing to the increasing number of patients suffering from acute ischemic stroke in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of acute ischemic strokes
      • 3.4.1.2. Introduction of technologically advanced products
      • 3.4.1.3. Rising Adoption of unhealthy lifestyle
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Stringent and complex regulatory framework
      • 3.4.2.2. Risks associated with the neurothrombectomy devices
  • 3.5. Neurothrombectomy Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Clot Retrievers
    • 4.1.2. Aspiration/Suction Devices
    • 4.1.3. Vascular Snares
  • 4.2. Type Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Neurothrombectomy Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Clot Retrievers
      • 4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Aspiration/Suction Devices
      • 4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3 Vascular Snares
      • 4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospital
    • 5.1.2. Emergency Clinics
    • 5.1.3. Ambulatory Surgical Centers
  • 5.2. End-use Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurothrombectomy Devices Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospital
      • 5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Emergency Clinics
      • 5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Ambulatory Surgical Centers
      • 5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Acandis GmbH
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Phenox GmbH
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Stryker
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Penumbra, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Vesalio
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global neurothrombectomy devices market, by region 2018 - 2030 (USD Million)
  • Table 4 Global neurothrombectomy devices market, by product 2018 - 2030 (USD Million)
  • Table 5 Global neurothrombectomy devices market, by end-use 2018 - 2030 (USD Million)
  • Table 6 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 France neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 China neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurothrombectomy devices market: Market snapshot
  • Fig. 9 Neurothrombectomy devices market: Market segmentation
  • Fig. 10 Neurothrombectomy devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurothrombectomy devices market driver impact
  • Fig. 14 Neurothrombectomy devices market restraint impact
  • Fig. 15 Neurothrombectomy devices market Porter's five forces analysis
  • Fig. 16 Neurothrombectomy devices market PESTEL analysis
  • Fig. 17 Neurothrombectomy devices market segment dashboard
  • Fig. 18 Neurothrombectomy devices market: Product movement Analysis
  • Fig. 19 Clot retrievers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Aspiration/ suction devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Vascular snares market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Neurothrombectomy devices market: End-use movement Analysis
  • Fig. 23 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Emergency clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurothrombectomy devices market: Regional movement analysis
  • Fig. 27 Global neurothrombectomy devices market: Regional outlook and key takeaways
  • Fig. 28 Global market share, by region
  • Fig. 29 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)